Veterinary Medicine Information website

Biocan Novel DHPPi/L4R liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1088, Inactivated
Download as PDF

Product identification

Medicine name:
Biocan Novel DHPPi/L4R liofilizāts un suspensija suspensijas injekcijām pagatavošanai suņiem
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1088, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain CDV Bio 11/A, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain CAV-2-Bio 13, Live
    5.30
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    6.60
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
    5.10
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain MSLB 1090, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1091, Inactivated
    40.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1088, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/I/25/0017
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Vetmarket UAB
Destination wholesaler:
  • Vetmarket SIA